Apr 22 |
XORTX Announces Publication of Key Research in ADPKD
|
Apr 8 |
XORTX Announces Participation in Spring 2024 Investor Conferences
|
Mar 27 |
XORTX Announces New Clinical Advisory Board Member
|
Mar 19 |
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
|
Mar 19 |
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
|
Mar 11 |
XORTX Reprices Warrants Issued in Connection with Previous Private Placements
|
Mar 4 |
XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units
|
Feb 15 |
XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units
|
Feb 2 |
XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units
|
Jan 15 |
XORTX Announces $2 Million Public Offering
|